Vol 17, No 2 (2024)
Case report
Published online: 2024-08-16

open access

Page views 200
Article views/downloads 63
Get Citation

Connect on Social Media

Connect on Social Media

Atypical skin and mucosal lesions with renal involvement in ANCA vasculitis - a case report.

Agata Betlejewska1, Sylwia Wrzos1, Karolina Gwiazda-Tyndel1, Izabela Natalia Zakrocka1, Wojciech Załuska1
Renal Disease and Transplantation Forum 2024;17(2):59-64.

Abstract

Systemic vasculitis is a group of connective tissue diseases in which blood vessel wall is destroyed due to inflammatory process. It is a very heterogeneous clinical entity in which symptoms depend on the caliber of vessels and organs involved. Symptoms are often associated with changes in the vasculature of the skin, kidneys and the upper or lower respiratory tract. The onset of the disease can be very clandestine or highly nonspecific, which makes a quick and accurate diagnosis extremely difficult. A definitive diagnosis is sometimes not made until patient present with severe symptoms, including alveolar hemorrhage with respiratory failure or acute kidney injury, requiring urgent hospitalization. Skin and mucosal lesions are known to be related with the severity of organ involvement and can be specific for various types of vasculitis. Since in most cases they occur simultaneously or after the onset of general symptoms, they can help to make the right diagnosis. Presented study is a brief case report of a patient with atypical skin and mucosal lesions, admitted due to acute kidney injury, anemia, and rhabdomyolysis, in whom anti-neutrophil cytoplasmic antibodies (ANCA) vasculitis was diagnosed. Systemic vasculitis is a rare group of diseases that can be life-threatening. For this reason, it is of utmost importance to make a proper diagnosis, especially in patients with unclear, difficult to treat, recurrent and atypical symptoms. Delayed diagnosis and targeted treatment may lead to advanced and irreversible organ damage. Vasculitis should be taken under consideration in patients with atypical skin and mucosal lesions.

Article available in PDF format

View PDF

References

  1. Berden A, Göçeroglu A, Jayne D, et al. Diagnosis and management of ANCA associated vasculitis. BMJ. 2012; 344: e26.
  2. Gross WL, Trabandt A, Reinhold-Keller E. Diagnosis and evaluation of vasculitis. Rheumatology (Oxford). 2000; 39(3): 245–252.
  3. Gibson LE. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation. Int J Dermatol. 2022; 61(12): 1442–1451.
  4. Micheletti RG, Chiesa Fuxench Z, Craven A, et al. DCVAS Investigators. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2020; 72(10): 1741–1747.
  5. Marzano AV, Raimondo MG, Berti E, et al. Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis. Clin Rev Allergy Immunol. 2017; 53(3): 428–438.
  6. Esson GA, Hussain AB, Meggitt SJ, et al. Cutaneous manifestations of acute kidney injury. Clin Kidney J. 2022; 15(5): 855–864.
  7. Natsaki E, Watts RA, Scott DGI. Epidemiology of ANCA-associated Vasculitis. Rheum Dis Clin North Am. 2010; 36(3): 447–461.
  8. Kronbichler A, Bajema IM, Bruchfeld A, et al. Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024; 403(10427): 683–698.
  9. Chen KR. Skin involvement in ANCA-associated vasculitis. Clin Exp Nephrol. 2013; 17(5): 676–682.
  10. Mohamed N, Dacy NN, Lopez LM, et al. Secondary syphilis presenting as leukocytoclastic vasculitis in a 61-year-old man. Dermatol Online J. 2023; 29(5).
  11. Rhodes RH, Love GL, Da Silva Lameira F, et al. Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains. Diagn Pathol. 2024; 19(1): 33.
  12. Way A, Weinstein E. A Rare Case of Infliximab-Induced Small Vessel Vasculitis With Renal Involvement. J Investig Med High Impact Case Rep. 2023; 11: 23247096231188247.